The period prevalence of double expression diffuse large B-cell lymphoma patients and its associated risk factors and treatment response in Hospital Universiti Sains Malaysia from 2004 to 2015

QR Code

The period prevalence of double expression diffuse large B-cell lymphoma patients and its associated risk factors and treatment response in Hospital Universiti Sains Malaysia from 2004 to 2015

Background and Objective: Diffuse Large B-Cell Lymphoma (DLBCL) is a heterogeneous and complex disease. Its protein expression of MYC and BCL2 and/or BLC6 (Double Expression) is associated with poor response to standard treatment, thus poor prognosis. The aim is to determine the period prevalence o...

Full description

Bibliographic Details
Main Author:	Yong, Teh Chee
Format:	Thesis
Language:	English
Published:	2017
Subjects:	RC Internal medicine
Online Access:	http://eprints.usm.my/45621/ http://eprints.usm.my/45621/1/Dr.%20Teh%20Chee%20Yong-24%20pages.pdf

Similar Items

Immunohistochemical expression of hedgehog proteins in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina
Published: (2016)

The immunohistochemical studies of double or triple protein lymphoma in diffuse large B-cell lymphoma and their correlation with clinicopathological parameters
by: Wahab, Wan Nor Najmiyah Wan Abdul
Published: (2017)

Identification of MYC/BCL2 double-expressers lymphomas in diffuse large B cell lymphoma patients and association with their prognostic parameters and survival rates: a single centre experience
by: Ahmad, Aliza, et al.
Published: (2022)

Diffuse large B-cell lymphoma presenting with extensive cutaneous infiltration.
by: Shamsudin, Norashikin, et al.
Published: (2012)

Methylation status of MGMT and SPOCK2 in diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2016)

Expression profile of HIP1R in B-cell subsets and in silico prediction of its functions in diffuse large B-cell lymphoma
by: Keng, Wong Kah
Published: (2018)

Patched-1 and smoothened, a hedgehog receptor and signal transducer are highly expressed in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina, et al.
Published: (2017)

Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases
by: Boyle, Terry, et al.
Published: (2017)

Diffuse large B-cell lymphoma of the small intestine in a patient with refractory coeliac disease.
by: Ahmad Affandi, Khairunisa, et al.
Published: (2019)

Epigenetic methylation status of P16, MGMT and SPOCK2 in diffuse Large B cell lymphoma
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2016)

The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma
by: Hedstrom, Gustav, et al.
Published: (2014)

Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas
by: Hirpara, J., et al.
Published: (2016)

TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype
by: Zainuddin, Norafiza, et al.
Published: (2008)

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
by: Morin, R., et al.
Published: (2010)

The Role Of 18F -FDG PET-CT In Assessing Bone Marrow Involvement In Diffuse Large B-Cell Lymphoma (DLBCL)
by: Nasir, Siti Maisarah Mohd
Published: (2018)

Pyrosequencing-based quantitative identification of p16 methylation in diffuse large B-cell lymphoma at two centres in the East Coast of Malaysia
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2016)

Epigenetic silencing status of p16INK4a and MGMT promoter regions identified qualitatively in diffuse large B cell lymphoma
by: Mohd Ridah, L Jalilah, et al.
Published: (2015)

Detection of p16INK4a (p16) methylation in diffuse large B-cell lymphoma using methylation-specific PCR
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2014)

Methylation-specific PCR Revealed Aberrant Promoter Gene Methylation of p16, MGMT and SPOCK2 in Diffuse Large B-cell Lymphoma
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2015)

Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2011)

Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
by: Dang, Chee Chean
Published: (2018)

MGMT and SPOCK2 promoter methylation in diffuse large B-Cell lymphoma: a study in two tertiary health centres in the East Coast of Malaysia
by: Norafiza Zainuddin,, et al.
Published: (2017)

MGMT and SPOCK2 promoter methylation in diffuse large B-Cell lymphoma: a study in two tertiary health centres in the East Coast of Malaysia = Metilasi promoter MGMT dan SPOCK2 dalam diffuse large B-cell lymphoma: satu kajian yang dijalankan di dua pusat Kesihatan di Pantai Timur Malaysia
by: Zainuddin, Norafiza, et al.
Published: (2017)

Qualitative detection of p16INK4a tumor suppressor gene methylation in diffuse large b-cell lymphoma using methylation-specific PCR
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2014)

p16 tumor suppressor gene methylation in diffuse large B cell lymphoma: a study of 88 cases at two hospitals in the east coast of Malaysia
by: Mohd Ridah, Lailatul Jalilah, et al.
Published: (2017)

Primary cutaneous anaplastic large cell lymphoma with lung metastasis
by: Esa, Nor Kamaruzaman, et al.
Published: (2016)

Group- based quantitative structural activity relationship analysis of B-cell Lymphoma Extra Large (BCL-XL) inhibitors
by: Abdul Samat, Nadia Hanis, et al.
Published: (2014)

Period prevalence and cumulative incidence of lamivudine resistance and its associated factor in chronic hepatitis B patient in Hospital Universiti Sains Malaysia (HUSM)
by: Ismail, Mohd Sharizan
Published: (2018)

Small cell variant of anaplastic large cell lymphoma with positive immunoreactivity for CD99
by: Mohd Sidik, Shiran, et al.
Published: (2008)

STAT5 induces miR-21 expression in cutaneous T cell lymphoma
by: Lindahl, Lise M., et al.
Published: (2016)

Cloning, Expression and Characterization of Hepatitis B Large Surface Antigen In Yeast System
by: Mohamad Sinang, Fazia
Published: (2010)

Anaplastic large cell lymphoma presenting as a soft tissue mass – A case report
by: Siti-Aishah M.A.,, et al.
Published: (2008)

Evaluation of signal transducer and activator of transcription 3 (STAT-3) protein expression in non-hodgkin lymphoma cases in Hospital Universiti Sains Malaysia
by: Muhamad, Izyan Rifhana
Published: (2023)

Trends in prevalence of HIV infection, hepatitis B and hepatitis C among Australian prisoners - 2004, 2007, 2010
by: Reekie, J., et al.
Published: (2014)

Rasgrp1 deficiency associated with diffuse mesangial sclerosis infantile nephrotic syndrome and Epstein-Barr virus-induced Hodgkin’s lymphoma
by: Mohamed Nashrudin, Khairoon Nisa, et al.
Published: (2025)

The Determinants of Bank Profitability in Vietnam during the period 2009-2015
by: LUU, HANH THU
Published: (2016)

Prevalence of Human T-Cell Lymphotropic Virus Type 1 and Chemosensitivity of Leukaemia and Lymphoma Cells in Adult Patients in Malaysia
by: Selvarajan, Viknesvaran
Published: (2007)

Towards Large Scale Spectral Problems via Diffusion Process
by: Li, Q., et al.
Published: (2017)

Follicular lymphomas without t(14;18) chromosomal translocations exhibit variation in BCL2 protein expression
by: Masir, N, et al.
Published: (2011)

Involvement of the P53 pathway and P161NK4A in the pathogenesis of b-cell lymphomas
by: Zainuddin, Norafiza
Published: (2011)